Skip to content

Testing How Well Homoeopathic Treatments Work For Irritable Bowel Syndrome

Assessing The Effectiveness Of LM Potencies In Homoeopathic Management Of Irritable Bowel Syndrome: A Single Blind Randomized Control Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077304
Enrollment
52
Registered
2024-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K90-K95- Other diseases of the digestive system Health Condition 2: K588- Other irritable bowel syndrome

Interventions

Intervention1: LM Potencies: Homeopathic medicines will be given in the form of LM Potencies that is in 0/1, 0/2, 0/3 etc. Dose: potencies will be prescribed in liquid form and it will be based on sy

Sponsors

Dr Preeti Pandey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosed patient of IBS according to Rome’s IV criteria will be considered. 2. Moderate to Severe NPRS (4 – 10) score patient will be considered. 3. Age group varying from 18 to 55 years of both genders will be considered. 4. All socio- economic status, ethnic group and occupations will be considered.

Exclusion criteria

Exclusion criteria: 1. Cases that do not satisfy the Rome’s criteria. 2. Patient who has Mild NPRS (1 – 3) score shall not be considered. 3. The geriatric and pediatric age groups and pregnant and lactating females. 4. Patient suffering from life threatening diseases and those who need emergency medical intervention.

Design outcomes

Primary

MeasureTime frame
To assess the effectiveness of the L.M Potencies in regular practice in cases of IBS.Timepoint: 6 months with follow-up in each 15 days.

Secondary

MeasureTime frame
To understand the impact of LM potency on improving quality of life measures for individuals with IBS.Timepoint: 6 months with follow-up in each 15 days.;To explore any potential differences in treatment outcomes based on patient demographics or baseline characteristics.Timepoint: The study duration will be 18 months.

Countries

India

Contacts

Public ContactDr Preeti Pandey

Bharati Vidyapeeth (Deemed to be University) Homoeopathic Medical College and Hospital, Pune

sushma.manhas@bharatividyapeeth.edu9822322533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026